17th International Conference on Malignant Lymphoma
The 17th International Conference on Malignant Lymphoma was held from June 13 to 17 in Lugano, Switzerland. The conference focused on the pathology, biology, and treatment of lymphoid neoplasms. It featured clinical case discussions, poster presentations, educational sessions, and more.
The trial assessed discontinuation of ibrutinib treatment in patients with indolent clinical forms of MCL.
The single-arm, phase II clinical trial enrolled 50 previously untreated patients with a median age of 69 years.
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.